600+ sources. One page. See who else covered it.
A formulation manufacturing unit of subsidiary Eugia Pharma Specialities near Hyderabad had earlier received four observations and an Official Action Indicated (OAI) status from the regulator
We haven't written up this one. The Hindu - Sci-Tech has the full story — the link below goes straight to it.
This is one outlet's version. Read the fullest account.
Outfitting cells in "invisibility cloaks" may offer an easier, less damaging treatment pathway for people with diabetes undergoing cell therapy, according to researchers at Penn State.
Last year's funding cuts to federal agencies that oversee foodborne illness outbreaks are being tested with the record cyclosporiasis outbreak in the U.S.
[spotlight] The regulation of complementary and alternative medicines in South Africa has been hotly contested in recent decades, including in court rooms.
Federal Medicaid dollars can no longer pay for gender-affirming care for youth. Doctors who treat trans kids say it will harm vulnerable people.
"Farewell my dearest mummy. I love you," Tay said in an Instagram post.
Abhay Soi, Chairman, Max Healthcare informed that a blanket price cap on private hospital room rents must be weighed against the need for new hospital beds and investment viability.